Mraz Amerine & Associates’s Chemours CC Stock Holding History

Mraz Amerine & Associates’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,882	Closed	-$217K	–	178
2023 Q2	$217K	Buy	+5,882	New	+$180K	0.05%	162
2021 Q3	–	Sell	-5,882	Closed	-$205K	–	173
2021 Q2	$205K	Buy	+5,882	New	+$195K	0.06%	162
2019 Q2	–	Sell	-5,882	Closed	-$219K	–	167
2019 Q1	$219K	Buy	+5,882	New	+$214K	0.07%	140
2018 Q4	–	Sell	-5,882	Closed	-$232K	–	156
2018 Q3	$232K	Hold	5,882	–	–	0.07%	142
2018 Q2	$261K	Hold	5,882	–	–	0.08%	134
2018 Q1	$287K	Hold	5,882	–	–	0.09%	118
2017 Q4	$294K	Sell	5,882 -27	-0.5%	-$1.41K	0.09%	117
2017 Q3	$299K	Sell	5,909 -80	-1%	-$3.77K	0.09%	118
2017 Q2	$227K	Hold	5,989	–	–	0.07%	130
2017 Q1	$241K	Buy	+5,989	New	+$180K	0.08%	127

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mraz Amerine & Associates's CC Position: Q3 2023 in Review

Mraz Amerine & Associates sold out of Chemours (CC) in Q3 2023, closing a stake of 5,882 shares — an estimated $217K sold.

Mraz Amerine & Associates first reported a position in CC in Q1 2017 and held it in 10 quarters. The position peaked at $299K in Q3 2017. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

Mraz Amerine & Associates reported no remaining Chemours position as of Q3 2023 after selling out during the quarter.
Mraz Amerine & Associates sold 5,882 Chemours shares in Q3 2023, an estimated $217K.
Mraz Amerine & Associates first reported a position in Chemours in Q1 2017 and held it in 10 quarters.
Mraz Amerine & Associates's Chemours position peaked at $299K in Q3 2017.
455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Mraz Amerine & Associates's 13F filing for Q3 2023, filed 13 Nov 2023.